CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
Sep. 30, 2013	Sep. 30, 2012
OPERATING ACTIVITIES:
Net income	$ 16,187	$ 1,037
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	21,706	21,632
Amortization, including accretion of debt discount	4,762	5,430
Deferred income taxes	(2,872)	(911)
Earnings of equity method investees	(396)	(443)
Gain on sale of fixed assets	44	(236)
Share-based compensation expense	4,142	3,583
Changes in operating assets and liabilities:
Accounts receivable, net	(11,918)	7,444
Inventories, net	(26,292)	8,579
Prepaid expenses and other	(2,492)	(1,106)
Accounts payable	10,672	(8,611)
Accrued expenses and other	8,901	3,631
Net cash provided by operating activities	22,444	40,029
INVESTING ACTIVITIES:
Capital expenditures	(18,522)	(20,243)
Proceeds from sale of fixed assets	94	490
Payment for additional interest in PST		(19,779)
Net cash used for investing activities	(18,428)	(39,532)
FINANCING ACTIVITIES:
Revolving credit facility borrowings		11,420
Revolving credit facility payments	(1,160)	(38,433)
Proceeds from issuance of other debt	21,574	21,315
Repayments of other debt	(22,262)	(37,973)
Other financing costs		(134)
Repurchase of Common Shares to satisfy employee tax withholding	(729)	(1,135)
Net cash used for financing activities	(2,577)	(44,940)
Effect of exchange rate changes on cash and cash equivalents	63	1,278
Net change in cash and cash equivalents	1,502	(43,165)
Cash and cash equivalents at beginning of period	44,555	78,731
Cash and cash equivalents at end of period	46,057	35,566
Supplemental disclosure of non-cash financing activities:
Change in fair value of interest rate swap	(1,019)	1,450
Issuance of Common Shares for acquisition of additional PST interest		$ 10,197

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.